Microhealth
Rare Disease-Focused Care Delivery and Evidence Generation Platform
About
* Category leading RWE platform generating differentiated data through combination of a provider community and patient-reported outcomes; delivering personalized and comparative evidence at the point of care * Singular network architecture and data capturing capabilities help identify patients with unmet needs in real-time; unlocking opportunities to improve health outcomes and additional revenue for pharma * Microhealth has achieved product-market fit in the hemophilia and rare blood disorders space Today, we are the world's leader in digital hematology: - Our US hemophilia network covers 33%+ of patients on prophylaxis and 50%+ of hemophilia treatment centers - Average active-user retention is 52 months - Trusted by leading pharmaceutical sponsors: Novo Nordisk, Sanofi, Roche and Pfizer Microhealth is a Y Combinator company (Summer 2015). YC-listed status: Active.
- Website
- microhealth.com
- Location
- Claymont, DE, USA; Remote
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Microhealth Bleeding Disorders — A digital health app for hemophilia and rare bleeding disorder patients to track treatment, manage health goals, and contribute to real-world evidence. · App
Links
- Y Combinator profileycombinator